Setting

Global Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Region: Trend Forecast and Growth Opportunity

Published: 18 Jan 2020 | Report Code: 10247333 | Pages: 161

Global human insulin market is expected to reach $53.16 billion by 2026, representing a 2019-2026 CAGR of 7.47%. Highlighted with 83 tables and 87 figures, this 161-page report “Global Human Insulin Market 2020-2026 by Product Type (Drugs, Delivery Devices), Application (Type 1 Diabetes, Type 2 Diabetes, Others), Distribution Channel, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global human insulin market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. In this report 2019 is the base year for market analysis, with estimates and forecast covering 2020-2026. (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view. The balanced (most likely) projection is used to quantify global human insulin market in every aspect of the classification from perspectives of Product Type, Application, Distribution Channel, and Region. Based on product type, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Human Insulin Drugs • Human Insulin Delivery Devices Based on product, the global Human Insulin Drugs market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Modern Human Insulin (further segmented into Long-acting, Rapid- acting, Premixed by type; further segmented into Lantus, Apidra, Levemir, NovoRapid/ NovoLog, Novomix, Humalog, Others by brand) • Traditional Human Insulin (further segmented into Short-acting, Intermediate & Rapid-acting, Premixed by type; further segmented into Humulin, Insuman, Novolin/Actrapid/Insulatard by brand) Based on product, the global Human Insulin Delivery Devices market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Syringes • Pens (further segmented into Disposable, Reusable, Pen needles) • Pumps • Others Based on application, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Type 1 Diabetes • Type 2 Diabetes • Gestational Diabetes and Prediabetes Based on distribution channel, the global market is segmented into the following sub-markets with annual revenue for 2019-2026 included in each section. • Hospital Pharmacies • Retail Pharmacies • Online Pharmacies Geographically, the following regions together with the listed national/local markets are fully investigated: • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka) • Europe (Germany, UK, France, Spain, Italy, Rest of Europe; Rest of Europe is further segmented into Russia, Denmark, Austria, Norway, Sweden, The Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania) • North America (U.S. and Canada) • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) • RoW (Saudi Arabia, UAE, South Africa) For each of the aforementioned regions and countries, market analysis and revenue data are available for 2019-2026. The breakdown of all regional markets by country and split of major national markets by Product Type, Application, and Distribution Channel over the study years (2019-2026) are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Specifically, potential risks associated with investing in global human insulin market are assayed quantitatively and qualitatively through GMD’s Risk Assessment System. According to the risk analysis and evaluation, Critical Success Factors (CSFs) are generated as a guidance to help investors & stockholders identify emerging opportunities, manage and minimize the risks, develop appropriate business models, and make wise strategies and decisions. Key Players: Astra Zeneca PLC Biocon Eli Lilly Exir Julphar Novo Nordisk AS Pfizer Sanofi Aventis Sedico Wockhardt (Please Note: The report will be updated before delivery to make sure that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Table Of Contents

1 Introduction	8
1.1 Industry Definition and Research Scope	8
1.1.1 Industry Definition	8
1.1.2 Research Scope	9
1.2 Research Methodology	11
1.2.1 Overview of Market Research Methodology	11
1.2.2 Market Assumption	12
1.2.3 Secondary Data	12
1.2.4 Primary Data	12
1.2.5 Data Filtration and Model Design	13
1.2.6 Market Size/Share Estimation	14
1.2.7 Research Limitations	15
1.3 Executive Summary	16
2 Market Overview and Dynamics	18
2.1 Market Size and Forecast	18
2.2 Major Growth Drivers	19
2.3 Market Restraints and Challenges	22
2.4 Emerging Opportunities and Market Trends	25
2.5 Porter’s Fiver Forces Analysis	28
3 Segmentation of Global Market by Product Type	32
3.1 Market Overview by Product Type	32
3.2 Human Insulin Drugs	34
3.3 Human Insulin Delivery Devices	35
4 Segmentation of Global Human Insulin Drugs Market by Drug Product	36
4.1 Market Overview by Drug Product	36
4.2 Modern Human Insulin	38
4.2.1 Modern Human Insulin by Type	40
4.2.2 Modern Human Insulin by Brand	43
4.3 Traditional Human Insulin	50
4.3.1 Traditional Human Insulin by Type	52
4.3.2 Traditional Human Insulin by Brand	55
5 Segmentation of Global Human Insulin Delivery Devices Market by Device Product	58
5.1 Market Overview by Product	58
5.2 Syringes	60
5.3 Pens	61
5.4 Pumps	62
5.5 Other Devices	63
6 Segmentation of Global Market by Application	64
6.1 Market Overview by Application	64
6.2 Type 1 Diabetes	66
6.3 Type 2 Diabetes	67
6.4 Gestational Diabetes and Prediabetes	68
7 Segmentation of Global Market by Distribution Channel	69
7.1 Market Overview by Distribution Channel	69
7.2 Hospital Pharmacies	71
7.3 Retail Pharmacies	72
7.4 Online Pharmacies	73
8 Segmentation of Global Market by Region	74
8.1 Geographic Market Overview 2019-2026	74
8.2 North America Market 2019-2026 by Country	78
8.2.1 Overview of North America Market	78
8.2.2 U.S. Market	81
8.2.3 Canadian Market	85
8.3 European Market 2019-2026 by Country	87
8.3.1 Overview of European Market	87
8.3.2 Germany	90
8.3.3 UK	92
8.3.4 France	94
8.3.5 Spain	96
8.3.6 Italy	98
8.3.7 Rest of European Market	100
8.4 Asia-Pacific Market 2019-2026 by Country	102
8.4.1 Overview of Asia-Pacific Market	102
8.4.2 Japan	105
8.4.3 China	108
8.4.4 Australia	110
8.4.5 India	112
8.4.6 South Korea	114
8.4.7 Rest of APAC Region	116
8.5 Latin America Market 2019-2026 by Country	118
8.5.1 Argentina	121
8.5.2 Brazil	123
8.5.3 Mexico	125
8.5.4 Rest of Latin America Market	127
8.6 Rest of World Market 2019-2026 by Country	128
8.6.1 UAE	131
8.6.2 Saudi Arabia	133
8.6.3 South Africa	135
8.6.4 Other National Markets	137
9 Competitive Landscape	138
9.1 Overview of Key Vendors	138
9.2 New Product Launch, Partnership, Investment, and M&A	142
9.3 Company Profiles	144
Astra Zeneca PLC	144
Biocon	146
Eli Lilly	147
Exir	148
Julphar	149
Novo Nordisk AS	150
Pfizer	151
Sanofi Aventis	152
Sedico	153
Wockhardt	154
10 Investing in Global Market: Risk Assessment and Management	155
10.1 Risk Evaluation of Global Market	155
10.2 Critical Success Factors (CSFs)	158
Related Reports and Products	161
List Of Tables

Table 1.  Snapshot of Global Human Insulin Market, 2019-2026	17
Table 2.  Main Product Trends and Market Opportunities in Global Human Insulin Market	25
Table 3. Global Human Insulin Market by Product Type, 2019-2026, $ mn	32
Table 4. Global Human Insulin Drugs Market by Product, 2019-2026, $ mn	36
Table 5. Global Human Insulin Drugs Market: Modern Human Insulin by Type, 2019-2026, $ mn	39
Table 6. Global Human Insulin Drugs Market: Modern Human Insulin by Brand, 2019-2026, $ mn	39
Table 7. Global Human Insulin Drugs Market: Traditional Human Insulin by Type, 2019-2026, $ mn	51
Table 8. Global Human Insulin Drugs Market: Traditional Human Insulin by Brand, 2019-2026, $ mn	51
Table 9. Global Human Insulin Delivery Devices Market by Product, 2019-2026, $ mn	58
Table 10. Global Human Insulin Delivery Devices Market: Pens by Product, 2019-2026, $ mn	61
Table 11. Global Human Insulin Market by Application, 2019-2026, $ mn	64
Table 12. Global Human Insulin Market by Distribution Channel, 2019-2026, $ mn	69
Table 13. Global Human Insulin Market by Region, 2019-2026, $ mn	75
Table 14.  Leading National Human Insulin Market, 2019 and 2026, $ mn	77
Table 15. North America Human Insulin Market by Country, 2019-2026, $ mn	80
Table 16. U.S. Human Insulin Market by Product Type, 2019-2026, $ mn	83
Table 17. U.S. Human Insulin Market by Application, 2019-2026, $ mn	83
Table 18. U.S. Human Insulin Market by Distribution Channel, 2019-2026, $ mn	83
Table 19. Canada Human Insulin Market by Product Type, 2019-2026, $ mn	86
Table 20. Canada Human Insulin Market by Application, 2019-2026, $ mn	86
Table 21. Canada Human Insulin Market by Distribution Channel, 2019-2026, $ mn	86
Table 22. Europe Human Insulin Market by Country, 2019-2026, $ mn	89
Table 23. Germany Human Insulin Market by Product Type, 2019-2026, $ mn	91
Table 24. Germany Human Insulin Market by Application, 2019-2026, $ mn	91
Table 25. Germany Human Insulin Market by Distribution Channel, 2019-2026, $ mn	91
Table 26. UK Human Insulin Market by Product Type, 2019-2026, $ mn	93
Table 27. UK Human Insulin Market by Application, 2019-2026, $ mn	93
Table 28. UK Human Insulin Market by Distribution Channel, 2019-2026, $ mn	93
Table 29. France Human Insulin Market by Product Type, 2019-2026, $ mn	95
Table 30. France Human Insulin Market by Application, 2019-2026, $ mn	95
Table 31. France Human Insulin Market by Distribution Channel, 2019-2026, $ mn	95
Table 32. Spain Human Insulin Market by Product Type, 2019-2026, $ mn	97
Table 33. Spain Human Insulin Market by Application, 2019-2026, $ mn	97
Table 34. Spain Human Insulin Market by Distribution Channel, 2019-2026, $ mn	97
Table 35. Italy Human Insulin Market by Product Type, 2019-2026, $ mn	99
Table 36. Italy Human Insulin Market by Application, 2019-2026, $ mn	99
Table 37. Italy Human Insulin Market by Distribution Channel, 2019-2026, $ mn	99
Table 38. Human Insulin Market in Rest of Europe by Country, 2019-2026, $ mn	101
Table 39. APAC Human Insulin Market by Country, 2019-2026, $ mn	104
Table 40. Japan Human Insulin Market by Product Type, 2019-2026, $ mn	107
Table 41. Japan Human Insulin Market by Application, 2019-2026, $ mn	107
Table 42. Japan Human Insulin Market by Distribution Channel, 2019-2026, $ mn	107
Table 43. China Human Insulin Market by Product Type, 2019-2026, $ mn	109
Table 44. China Human Insulin Market by Application, 2019-2026, $ mn	109
Table 45. China Human Insulin Market by Distribution Channel, 2019-2026, $ mn	109
Table 46. Australia Human Insulin Market by Product Type, 2019-2026, $ mn	111
Table 47. Australia Human Insulin Market by Application, 2019-2026, $ mn	111
Table 48. Australia Human Insulin Market by Distribution Channel, 2019-2026, $ mn	111
Table 49. India Human Insulin Market by Product Type, 2019-2026, $ mn	113
Table 50. India Human Insulin Market by Application, 2019-2026, $ mn	113
Table 51. India Human Insulin Market by Distribution Channel, 2019-2026, $ mn	113
Table 52. South Korea Human Insulin Market by Product Type, 2019-2026, $ mn	115
Table 53. South Korea Human Insulin Market by Application, 2019-2026, $ mn	115
Table 54. South Korea Human Insulin Market by Distribution Channel, 2019-2026, $ mn	115
Table 55. Human Insulin Market in Rest of APAC by Country, 2019-2026, $ mn	117
Table 56. Latin America Human Insulin Market by Country, 2019-2026, $ mn	120
Table 57. Argentina Human Insulin Market by Product Type, 2019-2026, $ mn	122
Table 58. Argentina Human Insulin Market by Application, 2019-2026, $ mn	122
Table 59. Argentina Human Insulin Market by Distribution Channel, 2019-2026, $ mn	122
Table 60. Brazil Human Insulin Market by Product Type, 2019-2026, $ mn	124
Table 61. Brazil Human Insulin Market by Application, 2019-2026, $ mn	124
Table 62. Brazil Human Insulin Market by Distribution Channel, 2019-2026, $ mn	124
Table 63. Mexico Human Insulin Market by Product Type, 2019-2026, $ mn	126
Table 64. Mexico Human Insulin Market by Application, 2019-2026, $ mn	126
Table 65. Mexico Human Insulin Market by Distribution Channel, 2019-2026, $ mn	126
Table 66. RoW Human Insulin Market by Country, 2019-2026, $ mn	130
Table 67. UAE Human Insulin Market by Product Type, 2019-2026, $ mn	132
Table 68. UAE Human Insulin Market by Application, 2019-2026, $ mn	132
Table 69. UAE Human Insulin Market by Distribution Channel, 2019-2026, $ mn	132
Table 70. Saudi Arabia Human Insulin Market by Product Type, 2019-2026, $ mn	134
Table 71. Saudi Arabia Human Insulin Market by Application, 2019-2026, $ mn	134
Table 72. Saudi Arabia Human Insulin Market by Distribution Channel, 2019-2026, $ mn	134
Table 73. South Africa Human Insulin Market by Product Type, 2019-2026, $ mn	136
Table 74. South Africa Human Insulin Market by Application, 2019-2026, $ mn	136
Table 75. South Africa Human Insulin Market by Distribution Channel, 2019-2026, $ mn	136
Table 76. Global Human Insulin Market by Key Vendor, 2019, $ mn	140
Table 77. Astra Zeneca PLC: Company Snapshot	144
Table 78. Astra Zeneca PLC: Business Segmentation	144
Table 79. Astra Zeneca PLC: Product Portfolio	145
Table 80. Astra Zeneca PLC: Revenue, 2016-2018, $ mn	145
Table 81. Astra Zeneca PLC: Recent Developments	145
Table 82.  Risk Evaluation for Investing in Global Market, 2019-2026	156
Table 83. Critical Success Factors and Key Takeaways	159
List Of Figures

Figure 1.  Research Method Flow Chart	11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation	14
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2026	16
Figure 4. Global Human Insulin Market, 2019-2026, $ mn	18
Figure 5. Primary Drivers and Impact Factors of Global Human Insulin Market	19
Figure 6. Primary Restraints and Impact Factors of Global Human Insulin Market	22
Figure 7. Porter’s Fiver Forces Analysis of Global Human Insulin Market	28
Figure 8. Breakdown of Global Human Insulin Market by Product Type, 2019-2026, % of Revenue	32
Figure 9. Contribution to Global 2020-2026 Cumulative Revenue by Product Type, Value ($ mn) and Share (%)	33
Figure 10. Global Human Insulin Market: Human Insulin Drugs, 2019-2026, $ mn	34
Figure 11. Global Human Insulin Market: Human Insulin Delivery Devices, 2019-2026, $ mn	35
Figure 12. Breakdown of Global Human Insulin Drugs Market by Product, 2019-2026, % of Revenue	36
Figure 13. Contribution to Global Human Insulin Drugs Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%)	37
Figure 14. Global Human Insulin Market: Modern Human Insulin, 2019-2026, $ mn	38
Figure 15. Global Modern Human Insulin Market: Long-acting, 2019-2026, $ mn	40
Figure 16. Global Modern Human Insulin Market: Rapid- acting, 2019-2026, $ mn	41
Figure 17. Global Modern Human Insulin Market: Premixed, 2019-2026, $ mn	42
Figure 18. Global Modern Human Insulin Market: Lantus, 2019-2026, $ mn	43
Figure 19. Global Modern Human Insulin Market: Apidra, 2019-2026, $ mn	44
Figure 20. Global Modern Human Insulin Market: Levemir, 2019-2026, $ mn	45
Figure 21. Global Modern Human Insulin Market: NovoRapid/ NovoLog, 2019-2026, $ mn	46
Figure 22. Global Modern Human Insulin Market: Novomix, 2019-2026, $ mn	47
Figure 23. Global Modern Human Insulin Market: Humalog, 2019-2026, $ mn	48
Figure 24. Global Modern Human Insulin Market: Other Brands, 2019-2026, $ mn	49
Figure 25. Global Human Insulin Market: Traditional Human Insulin, 2019-2026, $ mn	50
Figure 26. Global Traditional Human Insulin Market: Short-acting, 2019-2026, $ mn	52
Figure 27. Global Traditional Human Insulin Market: Intermediate & Rapid-acting, 2019-2026, $ mn	53
Figure 28. Global Traditional Human Insulin Market: Premixed, 2019-2026, $ mn	54
Figure 29. Global Traditional Human Insulin Market: Humulin, 2019-2026, $ mn	55
Figure 30. Global Traditional Human Insulin Market: Insuman, 2019-2026, $ mn	56
Figure 31. Global Traditional Human Insulin Market: Novolin/Actrapid/Insulatard, 2019-2026, $ mn	57
Figure 32. Breakdown of Global Human Insulin Delivery Devices Market by Product, 2019-2026, % of Revenue	58
Figure 33. Contribution to Global Human Insulin Delivery Devices Cumulative Revenue by Product, 2020-2026, Value ($ mn) and Share (%)	59
Figure 34. Global Human Insulin Delivery Devices Market: Syringes, 2019-2026, $ mn	60
Figure 35. Global Human Insulin Delivery Devices Market: Pens, 2019-2026, $ mn	61
Figure 36. Global Human Insulin Delivery Devices Market: Pumps, 2019-2026, $ mn	62
Figure 37. Global Human Insulin Delivery Devices Market: Other Devices, 2019-2026, $ mn	63
Figure 38. Breakdown of Global Human Insulin Market by Application, 2019-2026, % of Revenue	64
Figure 39. Contribution to Global 2020-2026 Cumulative Revenue by Application, Value ($ mn) and Share (%)	65
Figure 40. Global Human Insulin Market: Type 1 Diabetes, 2019-2026, $ mn	66
Figure 41. Global Human Insulin Market: Type 2 Diabetes, 2019-2026, $ mn	67
Figure 42. Global Human Insulin Market: Gestational Diabetes and Prediabetes, 2019-2026, $ mn	68
Figure 43. Breakdown of Global Human Insulin Market by Distribution Channel, 2019-2026, % of Revenue	69
Figure 44. Contribution to Global 2020-2026 Cumulative Revenue by Distribution Channel, Value ($ mn) and Share (%)	70
Figure 45. Global Human Insulin Market: Hospital Pharmacies, 2019-2026, $ mn	71
Figure 46. Global Human Insulin Market: Retail Pharmacies, 2019-2026, $ mn	72
Figure 47. Global Human Insulin Market: Online Pharmacies, 2019-2026, $ mn	73
Figure 48.  Global Market Snapshot by Region	74
Figure 49.  Geographic Spread of Worldwide Human Insulin Market, 2019-2026, % of Revenue	75
Figure 50. Contribution to Global 2020-2026 Cumulative Revenue by Region, Value ($ mn) and Share (%)	76
Figure 51.  North American Human Insulin Market, 2019-2026, $ mn	79
Figure 52. Breakdown of North America Human Insulin Market by Country, 2019 and 2026, % of Revenue	79
Figure 53. Contribution to North America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	80
Figure 54. U.S. Human Insulin Market, 2019-2026, $ mn	82
Figure 55. Canada Human Insulin Market, 2019-2026, $ mn	85
Figure 56.  European Human Insulin Market, 2019-2026, $ mn	88
Figure 57. Breakdown of European Human Insulin Market by Country, 2019 and 2026, % of Revenue	88
Figure 58. Contribution to Europe 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	89
Figure 59.  Human Insulin Market in Germany, 2019-2026, $ mn	90
Figure 60.  Human Insulin Market in UK, 2019-2026, $ mn	92
Figure 61.  Human Insulin Market in France, 2019-2026, $ mn	94
Figure 62.  Human Insulin Market in Spain, 2019-2026, $ mn	96
Figure 63.  Human Insulin Market in Italy, 2019-2026, $ mn	98
Figure 64.  Human Insulin Market in Rest of Europe, 2019-2026, $ mn	100
Figure 65. Asia-Pacific Human Insulin Market, 2019-2026, $ mn	103
Figure 66. Breakdown of APAC Human Insulin Market by Country, 2019 and 2026, % of Revenue	103
Figure 67. Contribution to APAC 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	104
Figure 68.  Human Insulin Market in Japan, 2019-2026, $ mn	106
Figure 69.  Human Insulin Market in China, 2019-2026, $ mn	108
Figure 70.  Human Insulin Market in Australia, 2019-2026, $ mn	110
Figure 71.  Human Insulin Market in India, 2019-2026, $ mn	112
Figure 72.  Human Insulin Market in South Korea, 2019-2026, $ mn	114
Figure 73.  Human Insulin Market in Rest of APAC, 2019-2026, $ mn	116
Figure 74. Latin America Human Insulin Market, 2019-2026, $ mn	119
Figure 75. Breakdown of Latin America Human Insulin Market by Country, 2019 and 2026, % of Revenue	119
Figure 76. Contribution to Latin America 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	120
Figure 77.  Human Insulin Market in Argentina, 2019-2026, $ mn	121
Figure 78.  Human Insulin Market in Brazil, 2019-2026, $ mn	123
Figure 79.  Human Insulin Market in Mexico, 2019-2026, $ mn	125
Figure 80.  Human Insulin Market in Rest of Latin America, 2019-2026, $ mn	127
Figure 81. Human Insulin Market in Rest of the World (RoW), 2019-2026, $ mn	129
Figure 82. Breakdown of RoW Human Insulin Market by Country, 2019 and 2026, % of Revenue	129
Figure 83. Contribution to RoW 2020-2026 Cumulative Revenue by Country, Value ($ mn) and Share (%)	130
Figure 84.  Human Insulin Market in UAE, 2019-2026, $ mn	131
Figure 85.  Human Insulin Market in Saudi Arabia, 2019-2026, $ mn	133
Figure 86.  Human Insulin Market in South Africa, 2019-2026, $ mn	135
Figure 87. Growth Stage of Global Human Insulin Industry over the Forecast Period	138
Astra Zeneca PLC	
Biocon	
Eli Lilly	
Exir	
Julphar	
Novo Nordisk AS	
Pfizer	
Sanofi Aventis	
Sedico	
Wockhardt